MedTrace Logo

Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery

NCT01799876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2019-01-10

No results posted yet for this study

Summary

The purpose of this study is to assess the potential benefit of enhancing knee surgery for cartilage injury using some of the patient's own cells, taken from fat tissue, that may be able to help cartilage to regenerate.

Conditions

  • Articular Cartilage Defect Grade III or IV of the Knee

Interventions

PROCEDURE

Autologous Cell

PROCEDURE

Standard microfracture arthroscopic surgery

Sponsors & Collaborators

  • InGeneron, Inc.

    collaborator INDUSTRY

  • Fondren Orthopedic Group L.L.P.

    lead OTHER

Principal Investigators

  • Robert L Burke, MD · Fondren Orthopedic Group L.L.P.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799876 on ClinicalTrials.gov